Prices Released for First 10 Drugs Selected in Medicare Negotiations
Drug Topics
AUGUST 15, 2024
New prices will go into effect on January 1, 2026, for individuals covered by Medicare Part D prescription drugs.
Thu.Aug 15, 2024
198 
CMS Announces Negotiated Prices for 10 Drugs Under Inflation Reduction Act
Pharmacy Times
AUGUST 15, 2024
The new prices are expected to go into effect for patients with Medicare Part D on January 1, 2026.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
STAT+: Medicare announces drug prices for historic first round of negotiations
STAT
AUGUST 15, 2024
WASHINGTON — The day drug makers dreaded has finally arrived. Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them. The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl
Co-Administering RSV and Influenza Vaccines Could Provide Tolerable Immune Responses
Pharmacy Times
AUGUST 15, 2024
RSV and influenza vaccines demonstrated hemagglutination inhibition titers that were noninferior to those with sequential administration.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Clinical trials exclude disabled Americans because federal agencies failed them, new report finds
STAT
AUGUST 15, 2024
People with disabilities are largely excluded from clinical trials that could benefit them because federal agencies have failed to update rules that govern how trials are conducted or neglected to enforce existing laws that protect disabled Americans against discrimination, a new report has found. The National Council on Disability, an independent federal agency, released the report this week detailing how several federal agencies implicitly and explicitly exclude people with disabilities from c
CMS: Negotiated drug prices would have saved Medicare $6B last year
Fierce Healthcare
AUGUST 15, 2024
The Centers for Medicare & Medicaid Services offered the first look at the potential savings generated by the first crop of Medicare drug price negotiations. | The Centers for Medicare & Medicaid Services offered the first look at the potential savings generated by the first crop of Medicare drug price negotiations.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Wolters Kluwer targets retail pharmacies with new digital solutions for medication education
Fierce Healthcare
AUGUST 15, 2024
Information services company Wolters Kluwer rolled out new digital solutions to help retail pharmacies go paperless in an online, mobile tech consumer world. | There is a need to revamp the retail pharmacy experience beyond providing patients with medication leaflets. Two new pharmacy solutions offer digital health content to provide pharmacy consumers with accessible medication and health information.
Arthritis patients resort to an inconvenient Medicare workaround to avoid pricey drugs
STAT
AUGUST 15, 2024
As many as 40,000 chronically ill seniors are choosing to endure uncomfortable, time-consuming intravenous infusions because Medicare doesn’t sufficiently cover far more convenient, and less distressing, at-home treatments with the arthritis drug Humira. When rheumatoid arthritis patients enroll in Medicare, switching from private insurance plans, self-administered medications such as Humira and Xeljanz become unaffordable overnight, thanks to the program’s convoluted pricing of at
FDA Grants Priory Review for Durvalumab to Treat Small Cell Lung Cancer
Pharmacy Times
AUGUST 15, 2024
The supplemental biologics license application was granted based on results from the ADRIATIC phase 3 trial among individuals with limited stage small cell lung cancer.
Antiviral used for mpox no better than placebo, NIH says
STAT
AUGUST 15, 2024
The National Institutes of Health said Thursday that an antiviral often used to treat mpox did not resolve patients’ symptoms faster than placebo in a randomized trial. The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its sporadic use over the years in parts of Africa and its wider use during the 2022 and 2023 outbreaks in the U.S. and Europe.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
As mpox outbreak spreads across Africa, Siga's antiviral Tpoxx misses the bar in Congo study
Fierce Pharma
AUGUST 15, 2024
Just as a new strain of mpox spreads across Africa, results from a preliminary analysis of a study that began during the 2022 viral outbreak stands to provide more clarity on the clinical benefit o | Despite missing the trial's primary endpoint of time to lesion resolution, the study suggested that the treatment may be most beneficial for those treated early and those with severe disease.
STAT+: The business of CRISPR’d medicine: Not great
STAT
AUGUST 15, 2024
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I’m really excited to see “Alien: Romulus” this weekend, which I’m told harkens back to the 1979 original. Great 1970s-era sci-fi movies and TV series that are not Star Wars: Space 1999, Battlestar Galactica, Planet of the Apes, Close Encounters of the Third Kind, and Logan’s Run.
Behind the Counter: Mastering Pseudoephedrine and Other Restricted OTC Medications
Pharmacy Times
AUGUST 15, 2024
Key opinion leaders analyze the efficacy, safety profile, and proper utilization of behind-the-counter medications such as pseudoephedrine products, exploring their mechanisms of action and potential adverse effects, while also providing strategies for pharmacists to identify contraindications, drug interactions, and appropriate dosing regimens for these medications.
STAT+: Boston’s lab market is in rough shape
STAT
AUGUST 15, 2024
When demand for office space cratered during the Covid-19 pandemic, many developers in the Boston area doubled down on building lab space instead. Lately, it sure seems like they went overboard. With life sciences buildings hitting the market at a much faster rate than they can be filled, the region’s lab vacancy rate has skyrocketed, to the point that the share of empty space available rivals that of the pandemic-battered office market.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Maintaining Good Oral Hygiene Is the Gateway to General Health and Well-Being
Pharmacy Times
AUGUST 15, 2024
Some individuals are still unaware of the significance of routine oral hygiene and its link to overall health
STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy
STAT
AUGUST 15, 2024
Lykos Therapeutics, whose MDMA-assisted psychotherapy for post-traumatic stress disorder was rejected late last week by U.S. regulators, announced Thursday that it would cut 75% of its staff, and that the company’s founder would step down from its board. “We take to heart the FDA’s decision and the additional work we will need to do to bring this pioneering therapy to market,” Jeff George, chairman of the board, said in a statement.
US court rules for AstraZeneca, erasing Pfizer's $107.5M jury award in patent infringement case
Fierce Pharma
AUGUST 15, 2024
Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the | Less than three months after a Delaware federal jury ordered AstraZeneca to pay $107.5 million to Pfizer in a patent infringement case, a Delaware judge has nullified the award and invalidated the patents behind the original lawsuit.
Opinion: HHS says it is working against climate change. But it’s really climate washing
STAT
AUGUST 15, 2024
The U.S. Department of Health and Human Services has stated it will do all that it can to mitigate the health care industry’s greenhouse gas emissions. The evidence suggests it is climate washing. Climate washing is defined as a government or business providing inadequate, inaccurate, misleading, or false public information about its climate policy ambitions or implementation efforts to reduce greenhouse gas emissions, especially when the claims are made without independent third-party as
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
AI as an inventor: Defining ownership in the pharma sector
pharmaphorum
AUGUST 15, 2024
AI's role in inventing new drugs raises questions about ownership rights in the pharmaceutical sector. Explore the complexities of defining ownership in drug discovery with AI technology.
STAT+: UnitedHealthcare’s latest contract dispute, this time with Trinity Health, leaves thousands out-of-network
STAT
AUGUST 15, 2024
A widespread, monthslong contract dispute between UnitedHealthcare and Trinity Health has created a confusing patchwork of disrupted access across multiple states. UnitedHealthcare is the country’s largest health insurer, so its contract disagreements with large health systems affect members across the country from one another, threatening access to dozens of hospitals and their affiliated physicians.
AstraZeneca said to be wavering on £450m UK vaccine plant
pharmaphorum
AUGUST 15, 2024
AstraZeneca's plan to invest £450m in a vaccines plant in the UK has been thrown into doubt by a bid to slash state aid, reports FT
We have mpox vaccines now. But how will they be distributed?
STAT
AUGUST 15, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Big news this morning, so let’s get straight into it.
As Fall Allergy Season Approaches, Encourage Patients to Begin Medicating Today
Drug Topics
AUGUST 15, 2024
Ragweed season begins in late August and can run through early November.
New Medicare drug prices, antimicrobial-resistant meningitis, unlucky American women
STAT
AUGUST 15, 2024
Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in your inbox. Almost exactly two years ago, the Inflation Reduction Act was signed into law, allowing Medicare to negotiate drug prices for the first time. Today, the agency announced how much it lowered the costs for 10 drugs in the first year of negotiation.
Social, Economic Barriers Impact Access to Opioid Use Disorder Medications
Drug Topics
AUGUST 15, 2024
Community pharmacies in counties with high racialized economic segregation had higher odds of restricting buprenorphine.
Listen: Drug pricing drops & psychedelics under fire
STAT
AUGUST 15, 2024
Are pharma companies still fearful of the Inflation Reduction Act? Will Lykos’ FDA rejection and recent publication retractions pull down the entire psychedelics industry? And what would you name a commercial psychotherapy treatment? We discuss all that and more on this week’s episode of “The Readout LOUD.
Despite Success of Vaccines for Children Program, Disparities Persist
Drug Topics
AUGUST 15, 2024
A CDC report called for “increased efforts” to ensure parents can obtain all recommended vaccines for their eligible children and realize the full potential of the VFC program.
Incyte builds GvHD presence with Niktimvo approval
pharmaphorum
AUGUST 15, 2024
FDA clears Incyte's potential blockbuster Niktimvo as a treatment for chronic GvHD, making it a companion to the company's Jakafi for the disorder.
New Solutions from UpToDate Offer Accessible, Sustainable Patient Education
Drug Topics
AUGUST 15, 2024
As the role of pharmacists continues to change, new digital tools can help improve medication adherence and patient outcomes.
Allstate sells off employer voluntary benefits unit in $2B deal
Fierce Healthcare
AUGUST 15, 2024
Insurance giant Allstate will sell off its employer voluntary benefits arm to StanCorp Financial Group, also known as the Standard, in a deal valued at $2 billion. | Insurance giant Allstate will sell off its employer voluntary benefits arm to StanCorp Financial Group, also known as the Standard, in a deal valued at $2 billion.
AI chatbots struggle to interpret patient descriptions
pharmaphorum
AUGUST 15, 2024
Large language models (LLMs) find it hard to identify genetic conditions based on patient-written descriptions, say NIH researchers.
ELM-2 Trial Indicates Odronextamab Effective, Safe in Patients With Follicular Lymphoma
Pharmacy Times
AUGUST 15, 2024
Building off the positive results of ELM-1, the ELM-2 trial found intravenously administered odronextamab was safe and effective in patients with relapsed or refractory follicular lymphoma.
How clinical trials can use AI responsibly and effectively
Pharmaceutical Technology
AUGUST 15, 2024
Strong measures must be in place to safeguard confidential patient data when deploying AI to optimise clinical trial translations.
Let's personalize your content